Phibro Animal Health (PAHC) to Release Quarterly Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) is anticipated to announce its earnings results after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $292.26 million for the quarter. Phibro Animal Health has set its FY 2025 guidance at 1.340-1.480 EPS.Parties that are interested in registering for the company's conference call can do so using this link.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.35 earnings per share for the quarter, topping analysts' consensus estimates of $0.23 by $0.12. The business had revenue of $260.40 million for the quarter, compared to analyst estimates of $277.76 million. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. During the same quarter in the previous year, the firm earned $0.14 earnings per share. On average, analysts expect Phibro Animal Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Phibro Animal Health Stock Performance

PAHC stock traded down $0.17 during trading on Friday, reaching $21.81. The company had a trading volume of 164,917 shares, compared to its average volume of 131,648. The company has a market cap of $883.31 million, a price-to-earnings ratio of 50.72, a price-to-earnings-growth ratio of 0.56 and a beta of 0.53. Phibro Animal Health has a twelve month low of $10.03 and a twelve month high of $25.98. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. The firm has a 50-day simple moving average of $21.98 and a 200-day simple moving average of $21.54.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were given a dividend of $0.12 per share. The ex-dividend date was Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.20%. Phibro Animal Health's dividend payout ratio is currently 111.63%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. StockNews.com upgraded Phibro Animal Health from a "buy" rating to a "strong-buy" rating in a research note on Wednesday. Barclays raised their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a research report on Tuesday, November 12th. Finally, Morgan Stanley upped their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $20.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.